These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32859674)

  • 1. High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion.
    Elshof J; Hebbink RHJ; Duiverman ML; Hagmeijer R
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32859674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion.
    Li J; Fink JB; Ehrmann S
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32859677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion.
    Li J; Fink JB; Ehrmann S
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32299867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High flow nasal cannula is a good treatment option for COVID-19.
    Geng S; Mei Q; Zhu C; Yang T; Yang Y; Fang X; Pan A
    Heart Lung; 2020; 49(5):444-445. PubMed ID: 32295710
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-flow nasal cannula oxygen and potential nosocomial spread of COVID-19.
    Goldhaber-Fiebert SN; Greene JA; Garibaldi BT
    Br J Anaesth; 2020 Sep; 125(3):e309-e310. PubMed ID: 32425208
    [No Abstract]   [Full Text] [Related]  

  • 6. The utility of high-flow nasal cannula oxygen therapy in the management of respiratory failure secondary to COVID-19 pneumonia.
    Lalla U; Allwood BW; Louw EH; Nortje A; Parker A; Taljaard JJ; Moodley D; Koegelenberg CFN
    S Afr Med J; 2020 May; 110(6):12941. PubMed ID: 32880537
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving the Safety of High-Flow Therapies in the Management of Patients With COVID-19.
    Madney YM; Esquinas AM; Saeed H; Harb HS; Abdelrahim MEA
    Chest; 2020 Oct; 158(4):1788-1789. PubMed ID: 33036099
    [No Abstract]   [Full Text] [Related]  

  • 8. [The risk and prevention of bio-aerosol transmission in dental clinics].
    Yang YJ; Zhao JJ; Zhu YQ
    Shanghai Kou Qiang Yi Xue; 2020 Apr; 29(2):127-132. PubMed ID: 32626873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients.
    Remy KE; Lin JC; Verhoef PA
    Crit Care; 2020 Apr; 24(1):169. PubMed ID: 32326959
    [No Abstract]   [Full Text] [Related]  

  • 10. Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure.
    Honore PM; Barreto Gutierrez L; Kugener L; Redant S; Attou R; Gallerani A; De Bels D
    Crit Care; 2020 Aug; 24(1):482. PubMed ID: 32753062
    [No Abstract]   [Full Text] [Related]  

  • 11. High flow nasal cannula in COVID-19: a literature review.
    Gürün Kaya A; Öz M; Erol S; Çiftçi F; Çiledağ A; Kaya A
    Tuberk Toraks; 2020 Jul; 68(2):168-174. PubMed ID: 32755117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is spinal anaesthesia an aerosol-generating procedure? Transmission of SARS-CoV-2 from patient to anaesthetist.
    Plaat F; Campbell JP
    Br J Anaesth; 2020 Sep; 125(3):e315. PubMed ID: 32593457
    [No Abstract]   [Full Text] [Related]  

  • 13. Droplet evacuation strategy for simulated coughing during aerosol-generating procedures in COVID-19 patients.
    Tsui BCH; Deng A; Lin C; Okonski F; Pan S
    Br J Anaesth; 2020 Sep; 125(3):e299-e301. PubMed ID: 32600805
    [No Abstract]   [Full Text] [Related]  

  • 14. Droplet nuclei aerosol and Covid 19 - a risk to healthcare staff.
    Rao Us V; Arakeri G; Subash A; Thakur S
    Br J Oral Maxillofac Surg; 2020 Sep; 58(7):870-871. PubMed ID: 32553509
    [No Abstract]   [Full Text] [Related]  

  • 15. High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU.
    Guy T; Créac'hcadec A; Ricordel C; Salé A; Arnouat B; Bizec JL; Langelot M; Lineau C; Marquette D; Martin F; Lederlin M; Jouneau S
    Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32859678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Transmission and the Risk of Aerosol-Generating Procedures.
    Pasnick S; Carlos WG; Dela Cruz CS; Gross JE; Garrison G; Jamil S
    Am J Respir Crit Care Med; 2020 Aug; 202(4):P13-P14. PubMed ID: 32795140
    [No Abstract]   [Full Text] [Related]  

  • 17. Aerosol transmission of SARS-CoV-2: The unresolved paradox.
    Priyanka ; Choudhary OP; Singh I; Patra G
    Travel Med Infect Dis; 2020; 37():101869. PubMed ID: 32891726
    [No Abstract]   [Full Text] [Related]  

  • 18. Put a lid on it: are faecal bio-aerosols a route of transmission for SARS-CoV-2?
    McDermott CV; Alicic RZ; Harden N; Cox EJ; Scanlan JM
    J Hosp Infect; 2020 Jul; 105(3):397-398. PubMed ID: 32315667
    [No Abstract]   [Full Text] [Related]  

  • 19. Aerosol and surface persistence: Novel SARS-CoV-2 versus other coronaviruses.
    Krishan K; Kanchan T
    J Infect Dev Ctries; 2020 Jul; 14(7):748-749. PubMed ID: 32794465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transportation of intubated COVID-19 patients: Bain circuit with underwater seal system is an option to prevent aerosol transmission.
    Kumar A; Kumar A; Kumar N; Sinha C; Kumar A
    J Clin Anesth; 2020 Oct; 65():109869. PubMed ID: 32417619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.